Related Experiment Video
Updated: Jul 7, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
[Dose-effect relationship between premature chromosome and irradiation dose]
Bo Jiang1, Qiang Liu, En-Hai Jiang
1Institute of Radiation Medicine, Chinese Academy of Medical Science, Tianjin 300020, China.
Summary
Premature chromosome condensation induced by Calyculin A shows a dose-effect relationship with gamma irradiation. This method can be utilized for accurate radiation biodosimetry.
Area of Science:
- Radiation Biology
- Cell Biology
- Genetics
Background:
- Radiation exposure necessitates accurate biodosimetry for effective medical and safety protocols.
- Assessing radiation dose effects on chromosomes is crucial for understanding biological damage.
- Calcyulin A is a known inducer of premature chromosome condensation (PCC).
Purpose of the Study:
- To investigate the relationship between gamma irradiation dose and Calyculin A-induced premature chromosome condensation.
- To establish the efficacy of Calyculin A-induced PCC as a biodosimetry tool.
Main Methods:
- Human peripheral blood samples were exposed to varying doses of (137)Cs gamma radiation (0-5.0 Gy).
- Premature chromosome condensation was induced using Calyculin A.
- Chromosomes were stained using centromeric banding techniques for analysis.
Main Results:
- A significant quadratic relationship was observed between irradiation dose and chromosomal aberrations, including total aberrations, fragments, and dicentric+centric ring (dic+r) counts.
- The observed dose-effect relationship provides a quantifiable basis for biodosimetry.
Conclusions:
- Premature chromosome condensation induced by Calyculin A serves as a reliable biomarker for radiation exposure.
- This technique offers a viable method for radiation biodosimetry, particularly in clinical and emergency scenarios.
Related Concept Videos
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...